FDA, CDC recommend pause in use of Johnson & Johnson s COVID vaccine over rare but unusual blood clots wsws.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wsws.org Daily Mail and Mail on Sunday newspapers.
AZ Covid-19 vaccine and blood clots: the risks explained
By Darcy Jimenez 12 Apr 2021 (Last Updated April 12th, 2021 15:32)
Health authorities in the UK and Europe have confirmed a possible link between the AstraZeneca Covid-19 vaccine and a small number of blood clot cases, but are yet to establish a definite causal relation. Despite no risk factors having been identified, some countries have paused use of the jab in younger age groups – so how worried should we be?
The EMA and MHRA have confirmed a possible link between AZ’s jab and “extremely rare” blood clot cases. Credit: Jernej Furman
Share Article
Apr 12, 2021 8:55am
The FDA is looking into reports of rare blood clots following the Johnson & Johnson vaccine, a spokeswoman said. (syahrir maulana/iStock/Getty Images Plus)
Drug regulators in Europe last week flagged rare but “serious” cases of blood clots in people who had received Johnson & Johnson’s COVID-19 vaccine. But it’s not just European regulators taking a close look at the shot’s safety profile the FDA is, too.
The FDA is “aware of reports in the U.S. of serious thromboembolic events” and has “not found a causal relationship with vaccination,” a spokeswoman said late Friday. The agency is continuing its investigation of the reports, which will “inform the potential need for regulatory action.”
European Union health ministers will hold a meeting on Wednesday on vaccine rollouts after the EU drugs regulator announces its decision on the safety of the AstraZeneca COVID-19 vaccine, the EU presidency said.
Paraguay to Give First Doses of AstraZeneca Only to People Over 55 - Health Ministry Sun 11th April 2021 | 08:00 AM
MOSCOW (UrduPoint News / Sputnik - 11th April, 2021) Paraguay has decided to stop administering the first shots of the AstraZeneca vaccine to people under the age of 55, the country s Ministry of Public Health and Social Welfare informs. The measure to stop immunization with this vaccine in people under 55 years of age is due to the precautionary principle, and absolutely does not undermine the safety of this vaccine, Dr. Hector Castro, director of the Expanded Immunization Program, said as quoted in the health ministry s Saturday release.